The shared neuroanatomy and neurobiology of comorbid chronic pain and PTSD: Therapeutic implications

Clinical Journal of Pain

Volumn 31, Issue 4, 2015, Pages 363-374

  Scioli Salter, Erica R ^a,c   Forman, Daniel E ^d   Otis, John D ^a,c   Gregor, Kristin ^a   Valovski, Ivan ^b   Rasmusson, Ann M ^c  

^a VA BOSTON HEALTHCARE SYSTEM   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Allopregnanolone; Chronic pain; Exercise; Neuropeptide Y; Posttraumatic stress disorder

Indexed keywords

3ALPHA HYDROXY 5ALPHA PREGNAN 20 ONE; ALPHA 2 ADRENERGIC RECEPTOR; C REACTIVE PROTEIN; CANNABINOID 1 RECEPTOR; ELTANOLONE; GAMMA INTERFERON; GLUCOCORTICOID RECEPTOR; HYDROCORTISONE; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 6; MU OPIATE RECEPTOR; NEUROPEPTIDE Y; TUMOR NECROSIS FACTOR ALPHA;

ACUTE STRESS; AMYGDALOID NUCLEUS; ANALGESIA; ANTINOCICEPTION; ANXIETY DISORDER; CHRONIC PAIN; COMORBIDITY; CONDITIONING; DEPOLARIZATION; DEPRESSION; EMOTIONAL STRESS; EXERCISE INTENSITY; FUNCTIONAL MAGNETIC RESONANCE IMAGING; FUNCTIONAL NEUROIMAGING; HUMAN; IMMUNE SYSTEM; MOLECULAR PATHOLOGY; NEUROANATOMY; NEUROBIOLOGY; NEUROTRANSMISSION; NOCICEPTION; NONHUMAN; OXIDATIVE STRESS; PAIN THRESHOLD; PHYSIOLOGICAL STRESS; POSTTRAUMATIC STRESS DISORDER; PREFRONTAL CORTEX; PRIORITY JOURNAL; REVIEW; SEX DIFFERENCE; STRESS; TRAUMATIC BRAIN INJURY; ANIMAL; PATHOLOGY; PATHOPHYSIOLOGY; STRESS DISORDERS, POST-TRAUMATIC;

ANIMALS; CHRONIC PAIN; COMORBIDITY; HUMANS; NEUROANATOMY; NEUROBIOLOGY; STRESS DISORDERS, POST-TRAUMATIC;

EID: 84925876564     PISSN: 07498047     EISSN: 15365409     Source Type: Journal    
DOI: 10.1097/AJP.0000000000000115     Document Type: Review

References (136)

1. Otis JD, Keane TM, Kerns RD. An examination of the relationship between chronic pain and post-traumatic stress disorder. J Rehabil Res Dev. 2003;40:397-405.
2. Beckham JC, Crawford AL, Feldman ME, et al. Chronic post-traumatic stress disorder and chronic pain in Vietnam combat veterans. J Psychosom Res. 1997;43:379-389.
3. Asmundson GJG, Coons MJ, Taylor S, et al. PTSD and the experience of pain: research and clinical implications of shared vulnerability and mutual maintenance models. Can J Psychiatry. 2002;47:930-937.
4. Geisser ME, Roth RS, Bachman JE, et al. The relationship between symptoms of post-traumatic stress disorder and pain, affective disturbance and disability among patients with accident and non-accident related pain. Pain. 1996;66:207-214.
5. Turk DC, Okifuji A. Perception of traumatic onset, compensation status, and physical findings: impact on pain severity, emotional distress, and disability in chronic pain patients. J Behav Med. 1996;19:435-453.
6. Scioli ER, Otis JD, Keane TM. Psychological problems associated with OEF/OIF deployment. Am J Lifestyle Med. 2009;4:349-359.
7. Shipherd JC, Keyes M, Jovanovic T, et al. Veterans seeking treatment for posttraumatic stress disorder: what about comorbid chronic pain? J Rehabil Res Dev. 2007;44:153-166.
8. Otis JD, Reid MC, Kerns RD. The management of chronic pain in the primary care setting. In: James LC, Folen RA, eds. Primary Care Clinical Health Psychology: A Model for the Next Frontier. Washington, DC: American Psychological Association Press; 2005:41-59.
9. Kulka RA, Schlenger WE, Fairbank JA, et al. Contractual Report of Findings from the National Vietnam Veterans' Readjustment Study: Volumes 1-4. North Carolina: Research Triangle Institute; 1988.
10. Bilmes Linda J. "Current and Projected Future Costs of Caring for Veterans of the Iraq and Afghanistan Wars." Costs of War. Providence, RI: Eisenhower Research Project, Watson Institute for International Studies, Brown University; 2012. Available at: http://costsofwar.org/article/caring-us-Veterans. Accessed January 5, 2011.
11. Pitman RK, Rasmusson AM, Koenen KC, et al. Biology of posttraumatic stress disorder. Nat Rev Neurosci. 2013;13:769-787.
12. Shalev A, Gilboa A, Rasmusson AM. Neurobiology of stress, trauma, and PTSD. In: Stein DJ, Friedman MJ, Blanco C, eds. Trauma and Mental Health: Resilience and Posttraumatic Stress Disorders. West Sussex, England: John Wiley & Sons Ltd.; 2012:89-138.
13. Goldstein LE, Rasmusson AM, Bunney BS, et al. Role of the amygdala in the coordination of behavioral, neuroendocrine and prefrontal cortical monoamine responses to psychological stress in the rat. J Neurosci. 1996;16:4787-4798.
14. Bernard JF, Besson JM. The spino(trigemino) pontoamygdaloid pathway: electrophysiological evidence for an involvement in pain processes. J Neurophysiol. 1990;63:473-490.
15. Bourgeais L, Gauriau C, Monconduit L, et al. Dendritic domains of nociceptive-responsive parabrachial neurons match terminal fields of lamina I neurons in the rat. J Comp Neurol. 2003;464:238-256.
16. Rosenkranz JA, Grace AA. Dopamine attenuates prefrontal cortical suppression of sensory inputs to the basolateral amygdala of rats. J Neurosci. 2001;21:4090-4103.
17. LeDoux JE. Brain mechanisms of emotion and emotional learning. Curr Opin Neurobiol. 1992;2:191-197.
18. Rosenkranz JA, Buffalari DM, Grace AA. Opposing influence of basolateral amygdala and footshock stimulation on neurons of the central amygdala. Biol Psychiatry. 2006;59:801-811.
19. Crock LW, Kolber BJ, Morgan CD, et al. Central amygdala metabotropic glutamate receptor 5 in the modulation of visceral pain. J Neurosci. 2012;32:14217-14226.
20. Han JS, Neugebauer V. mGluR1 and mGluR5 antagonists in the amygdala inhibit different components of audible and ultrasonic vocalizations in a model of arthritic pain. Pain. 2005;113:211-222.
21. Han JS, Li W, Neugebauer V. Critical role of calcitonin gene-related peptide1 receptors in the amygdala in synaptic plasticity and pain behavior. J Neurosci. 2005;25:10717-10728.
22. Carrasquillo Y, Gereau RW IV. Activation of the extracellular signal-regulated kinase in the amygdala modulates pain perception. J Neurosci. 2007;27:1543-1551.
23. Helmstetter FD, Belgowan PS. Lesions of the amygdala block conditional hypoalgesia in the tail flick test. Brain Res. 1992;612:253-257.
24. Otis JD, Keane TM, Kerns RD, et al. The development of an integrated treatment for veterans with comorbid chronic pain and posttraumatic stress disorder. Pain Med. 2009;10:1300-1311.
25. Rasmusson AM, Shalev A. Integrating the neuroendocrinology, neurochemistry, and neuroimmunology of PTSD to date and the challenges ahead. In: Friedman M, Keane T, Resick P, eds. Handbook of PTSD, Second Edition. New York, NY: Guilford Publications Inc.; 2014.
26. Taylor BK. NPY analgesia: moving from acute to chronic pain. In: Zukowska Z, Feuerstein G, eds. The NPY Family of Peptides in Immune Disorders, Inflammation, Angiogenesis and Cancer Progress. Basel, Switzerland: Inflammation Research; 2005:135-148.
27. Woolf CJ, Doubell TP. The pathophysiology of chronic pain - increased sensitivity to low threshold A B-fibre inputs. Curr Opin Neurobiol. 1994;4:525-534.
28. Tsvetkov E, Carlezon WA, Benes FM, et al. Fear conditioning occludes LTP-induced presynaptic enhancement of synaptic transmission in the cortical pathway to the lateral amygdala. Neuron. 2002;34:289-300.
29. Matsumoto K, Puia G, Dong E, et al. GABA-A receptor neurotransmission dysfunction in a mouse model of social isolation-induced stress: possible insights into a non-serotonergic mechanism of action of SSRIs in mood and anxiety disorders. Stress. 2007;10:3-12.
30. Mechlin B, Morrow AL, Maixner W, et al. The relationship of allopregnanolone immunoreactivity and HPA-axis measures to experimental pain sensitivity: evidence for ethnic differences. Pain. 2007;131:142-152.
31. Rasmusson AM, Pinna G, Paliwal P, et al. Decreased cerebrospinal fluid allopregnanolone levels in women with posttraumatic stress disorder. Biol Psychiatry. 2006;60:704-713.
32. Hokfelt T, Lundberg JM, Jansco G, et al. Avian pancreatic polypeptide (APP) immunoreactive neurons in the spinal cord and spinal trigeminal nucleus. Peptides. 1981;2:81-87.
33. Walker MW, Ewald DA, Perney TM, et al. Neuropeptide Y modulates neurotransmitter release and Ca2 + currents in rat sensory neurons. J Neurosci. 1988;8:2438-2446.
34. Taiwo OB, Taylor BK. Antihyperalgesic effects of intrathecal neuropeptide Y during inflammation are mediated by Y1 receptors. Pain. 2002;96:353-363.
35. Li J, Zhou X, Yu L. Involvement of neuropeptide Y and Y1 receptor in antinociception in the arcuate nucleus of hypothalamus, an immunohistochemical and pharmacological study in intact rats and rats with inflammation. Pain. 2005;118:232-242.
36. Upadhya MA, Dandekar MP, Kokare DM, et al. Involvement of neuropeptie Y in the acute, chronic and withdrawal responses of morphine in nociception in neuropathic rats: behavioral and neuroanatomical correlates. Neuropeptides. 2009;43:303-314.
37. Solway B, Bose SC, Corder G, et al. Tonic inhibition of chronic pain by neuropeptide Y. Proc Nat Acad Sci. 2011;108:7224-7229.
38. Ide S, Hara T, Ohno A, et al. Opposing roles of corticotropin-releasing factor and neuropeptide Y within the dorsolateral bed nucleus of the stria terminalis in the negative affective component of pain in rats. J Neurosci. 2013;33:5881-5894.
39. Zukowska-Grojec Z, Neuropeptide Y. a novel sympathetic stress hormone and more. Ann N Y Acad Sci. 1995;771:219-233.
40. Rasmusson AM, Schnurr P, Zukowska Z, et al. Adaptation to extreme stress: PTSD, NPY, and metabolic syndrome. Exp Biol Med. 2010;235:1150-1156.
41. Wahlestedt C, Reis DJ. Neuropeptide Y-related peptides and their receptors - are the receptors potential therapeutic drug targets? Ann Rev Pharmacol Toxicol. 1993;33:309-352.
42. Morgan CA III, Wang S, Southwick SM, et al. Plasma neuropeptide-Y concentrations in humans exposed to military survival training. Biol Psychiatry. 2000;47:902-909.
43. Morgan CA III, Rasmusson AM, Wang S, et al. Neuropeptide Y, cortisol, and subjective distress in humans exposed to acute stress: replication and extension of previous report. Biol Psychiatry. 2002;52:136-142.
44. Dimoulas E, Steffian G, Doran A, et al. Dissociation during intense military stress is related to subsequent somatic symptoms in women. Psychiatry. 2007;4:66-73.
45. Rasmusson AM, Hauger RL, Morgan CA III, et al. Low baseline and yohimbine-stimulated plasma neuropeptide Y (NPY) levels in combat-related PTSD. Biol Psychiatry. 2000; 47:526-539.
46. Sah R, Ekhator NN, Strawn JR, et al. Sallee Low cerebrospinal fluid neuropeptide Y concentrations in post-traumatic stress disorder. Biol Psychiatry. 2009;66:705-707.
47. Yehuda R, Brand S, Yank RK. Plasma neuropeptide Y concentrations in combat exposed veterans: relationship to trauma exposure, recovery from PTSD and coping. Biol Psychiatry. 2005;59:660-663.
48. Corder R, Castagne V, Rivet JM, et al. Central and peripheral effects of repeated stress and high NaCl diet on neuropeptide Y. Physiol Behav. 1992;52:205-210.
49. Morgan CA III, Rasmusson AM, Winters B, et al. Trauma exposure rather than posttraumatic stress disorder is associated with reduced baseline plasma neuropeptide-Y levels. Biol Psychiatry. 2003;54:1087-1091.
50. Seedat S, Stein MB, Kennedy CM, et al. Plasma cortisol and neuropeptide Y in female victims of intimate partner violence. Psychoneuroendocrinology. 2003;28:796-808.
51. Morgan CA III, Wang S, Mason J, et al. Hormone profiles in humans experiencing military survival training. Biol Psychiatry. 2000;47:891-901.
52. Mickey BJ, Zhou Z, Heitzeg MM, et al. Emotion processing, major depression, and functional genetic variation of neuropeptide Y. Arch Gen Psychiatry. 2011;68:158-166.
53. Zhou Z, Zhu G, Hariri AR, et al. Genetic variation in human NPY expression affects stress response and emotion. Nature. 2008;452:997-1001.
54. Lambert JJ, Belelli D, Peden DR, et al. Neurosteroid modulation of GABAA receptors. Prog Neurobiol. 2003;71:67-80.
55. Puia G, Mienville J-M, Matsumoto K, et al. On the putative physiological role of allopregnanolone on GABAA receptor function. Neuropharmacology. 2003;44:49-55.
56. Charlet A, Lesbennes F, Darbon P, et al. Fast non-genomic effects of progesterone-derived neurosteroids on nociceptive thresholds and pain symptoms. Pain. 2008;139:603-609.
57. Kavaliers M, Wiebe JP. Analgesic effects of the progesterone metabolite, 3 α-hydroxy-5 α-pregnan-20-one, and possible modes of action in mice. Brain Res. 1987;415:393-398.
58. Payne VM, Kilts JD, Naylor JC, et al. Allopregnanolone and pregnenolone alterations following pharmacological agents in rodents and clinical populations. In: Ritsner MS, Weizman A, eds. Neuroactive Steroids in Brain Function, Behavior and Neuropsychiatric Disorders: Novel Strategies for Research and Treatment. New York, NY: Springer Science & Business Media; 2008:369-383.
59. Cagetti E, Pinna G, Guidotti A, et al. Chronic intermittent ethanol (CIE) administration in rats decreases levels of neurosteroids in hippocampus, accompanied by altered behavioral responses to neurosteroids and memory function. Neuropharmacology. 2004;46:350-357.
60. Mitev YA, Darwish M, Wolf SS, et al. Gender differences in the regulation of 3-alpha-hydroxysteroid dehydrogenase in rat brain and sensitivity to neurosteroid-mediated stress protection. Neuroscience. 2003;120:541-549.
61. Hou Y-T, Lin H-K, Penning TM. Dexamethasone regulation of the Rat 3α-hydroxysteroid/dihydrodiol dehydrogenase gene. Mol Pharmacol. 1998;53:459-466.
62. Gillespie CF, Almli LM, Smith AK, et al. Sex dependent influence of a functional polymorphism in steroid 5-alpha-reductase type 2 (SRD5A2) on post-traumatic stress symptoms. Am J Med Genet B Neuropsychiatr Genet. 2013;162B:283-292.
63. Al-Hasani R, Bruchas MR. Molecular mechanisms of opioid receptor-dependent signaling and behavior. Anesthesiology. 2011;115:1363-1381.
64. Jordan BA, Gomes I, Rios C, et al. Functional interactions between mu opioid and alpha 2A-adrenergic receptors. Mol Pharmacol. 2003;64:1317-1324.
65. Stone L, MacMillan L, Kitto K, et al. The alpha2 adrenergic receptor subtype mediates spinal analgesia evoked by alpha2 agonists and is necessary for spinal adrenergic-opioid synergy. J Neurosci. 1997;18:7157-7165.
66. Perry BD, Giller EL, Southwick SM. Altered platelet alpha 2-adrenergic binding sites in posttraumatic stress disorder. Am J Psychiatry. 1987;144:1511-1512.
67. Maes M, Lin AH, Verkerk R, et al. Serotonergic and noradrenergic markers of post-traumatic stress disorder with and without major depression. Neuropsychopharmacology. 1999;20:188-197.
68. Colmers W, Bleakman D. Effects of neuropeptide Y on the electrical properties of neurons. Trends Neurosci. 1994;17:373-379.
69. Marsicano G, Wotjak CT, Azad SC, et al. The endogenous cannabinoid system controls extinction of aversive memories. Nature. 2002;418:530-534.
70. Chhatwal JP, Davis M, Maguschak KA, et al. Enhancing cannabinoid neurotransmission augments the extinction of conditioned fear. Neuropsychopharmacology. 2005;30:516-524.
71. Andero R, Heldt SA, Ye K, et al. Effect of 7,8-dihydroxyflavone, a small-molecule TrkB agonist, on emotional learning. Am J Psychiatry. 2013;168:163-172.
72. Zhang NR, Planer W, Siuda ER, et al. Serine 363 is required for nociceptin/orphanin FQ opioids receptor (NOPR) desensitization, internalization, and arrestin signaling. J Biol Chemistry. 2012;287:42019-42030.
73. 2 +-stimulated adenylyl cyclases in bidirectional synaptic plasticity and brain function. Rev Neurosci. 2012;23:67-78.
74. Ben Menachem-Zidon O, Avital A, Ben-Menahem Y, et al. Astrocytes support hippocampal-dependent memory and long-term potentiation via interleukin-1 signaling. Brain Behav Immun. 2011;25:1008-1016.
75. Gill J, Vythilingam M, Page GG. Low cortisol, high DHEA, and high levels of stimulated TNF-α, and IL-6 in women with PTSD. JJ Trauma Stress. 2008;21:530-539.
76. Baker DG, Nievergelt CM, O'Connor DT. Biomarkers of PTSD: neuropeptides and immune signaling. Neuropharmacology. 2012;62:663-673.
77. Gill J, Luckenbaugh D, Charney D, et al. Sustained elevation of serum interleukin-6 and relative insensitivity to hydrocortisone differentiates posttraumatic stress disorder with and without depression. Biol Psychiatry. 2010;68:999-1006.
78. Rasmusson AM, Picciotto MR, Krishnan-Sarin S. Smoking as a complex but critical covariate in neurobiological studies of posttraumatic stress disorders: a review. J Psychopharmacol. 2006;20:693-707.
79. Koenen KC, Hitsman B, Lyons MJ, et al. A twin registry study of the relationship between posttraumatic stress disorder and nicotine dependence in men. Arch Gen Psychiatry. 2005;62:1258-1265.
80. Zale EL, Meagher MM. Pain, nicotine, and smoking: research findings and mechanistic considerations. Psychol Bull. 2011;137:1065-1093.
81. Patterson AL, Gritzner S, Resnick MP, et al. Smoking cigarettes as a coping strategy for chronic pain is associated with greater pain intensity and poorer pain-related function. J Pain. 2012;13:285-292.
82. Neeck G. Neuroendocrine and hormonal perturbations and relations to the serotonergic system in fibromyalgia patients. Scand J Rheumatol. 2000;29:8-12.
83. Cohen H, Neumann L, Haiman Y, et al. Prevalence of post-traumatic stress disorder in fibromyalgia patients: overlapping syndromes or post-traumatic fibromyalgia syndrome? Semin Arthritis Rheum. 2002;32:38-50.
84. Weissbecker I, Floyd A, Dedert E, et al. Childhood trauma and diurnal cortisol disruption in fibromyalgia syndrome. Psychoneuroendocrinology. 2006;31:312-324.
85. Lemieux AM, Coe CL. Abuse-related posttraumatic stress disorder: evidence for chronic neuroendocrine activation in women. Psychosom Med. 1995;57:105-115.
86. Heim C, Ehlert U, Hanker JP, et al. Abuse-related posttraumatic stress disorder and alterations of the hypothalamic-pituitary-adrenal axis in women with chronic pelvic pain. Psychosom Med. 1998;60:309-318.
87. Rasmusson AM, Lipschitz DS, Wang S, et al. Increased pituitary and adrenal reactivity in premenopausal women with posttraumatic stress disorder. Biol Psychiatry. 2001;50:965-977.
88. Young EA, Breslau N. Cortisol and catecholamines in posttraumatic stress disorder: an epidemiologic community study. Arch Gen Psychiatry. 2004;61:394-401.
89. Klengel T, Mehta D, Anacker C, et al. Allele-specific FKBP5 DNA demethylation mediates gene-childhood trauma interactions. Nat Neurosci. 2013;16:33-41.
90. Hou YT, Lin HK, Penning TM. Dexamethasone regulation of the rat 3α-hydroxysteroid/dihydrodiol dehydrogenase gene. Mol Pharmacol. 1998;53:459-466.
91. Kuo J, Kitlinska JB, Tilan JU, et al. Neuropeptide Y acts directly in the periphery on fat tissue and mediates stress-induced obesity and metabolic syndrome. Nat Med. 2007;13:803-811.
92. McCain GA, Tilbe KS. Diurnal hormone variation in fibromyalgia syndrome: a comparison with rheumatoid arthritis. J Rheumatol. 1989;19:154-157.
93. Crofford LJ, Pillemer SR, Kalogeras KT, et al. Hypothalamic-pituitary-adrenal axis perturbations in patients with fibromyalgia. Arthritis Rheum. 1994;37:1583-1592.
94. Lentjes EG, Griep EN, Boersma JW, et al. Glucocorticoid receptors, fibromyalgia and low back pain. Psychoneuroendocrinology. 1997;22:603-614.
95. Griep EN, Boersma JW, Lentjes EG, et al. Function of the hypothalamic-pituitary-adrenal axis in patients with fibromyalgia and low back pain. J Rheumatol. 1998;25:1374-1381.
96. Yehuda R, Bierer LM, Sarapas C, et al. Cortisol metabolic predictors of response to psychotherapy for symptoms of PTSD in survivors of the World Trade Center attacks on September 11, 2001. Psychoneuroendocrinology. 2009;34:1304-1313.
97. Rustoen T, Wahl AK, Hanestad BR, et al. Gender differences in chronic pain - findings from a population-based study of Norwegian adults. Pain Manag Nurs. 2004;5:105-117.
98. Wijnjoven HAH, de Vet HCW, Picavet HSJ. Prevalence of musculoskeletal disorders is systematically higher in women than in men. Clin J Pain. 2006;22:717-724.
99. Plichta SB. Intimate partner violence and physical health consequences: policy and practice implications. J Interpers Violence. 2004;19:1296-1323.
100. Schomm JA, Briggs-Phillips M, Hobfoll SE. Cumulative interpersonal traumas and social support as risk and resiliency factors in predicting PTSD and depression among inner-city women. J Trauma Stress. 2006;19:825-836.
101. Hellstrom B, Lundberg U. Pain perception to the cold pressor test during the menstrual cycle in relation to estrogen levels and a comparison with men. Integr Psychol Behav Sci. 2000;35:132-142.
102. Hellstrom B. Pain perception across the menstrual phases in women with chronic pain. Percept Motor Skills. 2003;96:201-211.
103. Rasmusson AM, Friedman MJ. The neurobiology of PTSD in women. In: Kimerling R, Ouimette PC, Wolfe J, eds. Gender and Post-Traumatic Stress Disorder: Clinical, Research, and Program Level Applications. New York: Guilford Publications Inc.; 2002:43-75.
104. Nappi RE, Abbiati I, Luisi S, et al. Serum allopregnanolone levels relate to FSFI score during the menstrual cycle. J Sex Marital Ther. 2003;29:95-102.
105. Pinna G, Rasmusson AM. Upregulation of neurosteroid biosynthesis as a pharmacological strategy to improve behavioral deficits in a putative mouse model of PTSD. J Neuroendocrinology. 2012;24:102-116.
106. Linman C, Zeffiro TA, Pitman RK, et al. An fMRI study of unconditioned responses in post-traumatic stress disorder. Biol Mood Anxiety Disord. 2011;1:8.
107. Geuze E, Westenberg GM, Jochims A, et al. Altered pain processing in veterans with posttraumatic stress disorder. Arch Gen Psychiatry. 2007;64:76-85.
108. Mickelborough MJS, Daniels JK, Coupland NJ, et al. Effects of trauma-related cues on pain processing in posttraumatic stress disorder: an fMRI investigation. J Psychiatry Neurosci. 2011;36:6-14.
109. Defrin R, Ginzburg K, Soloman Z, et al. Quantitative testing of pain perception in subjects with PTSD - implications for the mechanism of the coexistence between PTSD and chronic pain. Pain. 2008;138:450-459.
110. McWilliams LA, Cox BJ, Enns MW. Mood and anxiety disorders associated with chronic pain: an examination in a nationally representative sample. Pain. 2003;106:127-133.
111. Dersh J, Polatin PB, Gatchel RJ. Chronic pain and psychopathology: research findings and theoretical considerations. Psychosom Med. 2002;64:773-786.
112. Lew HL, Otis JD, Tun C, et al. Prevalence of chronic pain, posttraumatic stress disorder, and persistent postconcussive symptoms in OIF/OEF veterans: polytrauma clinical triad. J Rehabil Res Dev. 2009;46:697-702.
113. Banks SM, Kerns RD. Explaining high rates of depression in chronic pain: a diathesis-stress framework. Psychol Bull. 1996;119:95-110.
114. Okie S. Traumatic brain injury in the war zone. N Engl J Med. 2005;352:2043-2047.
115. Warden D. Military TBI during the Iraq and Afghanistan wars. J Head Trauma Rehabil. 2006;21:398-402.
116. Lew HL, Poole JH, Alvarez S, et al. Soldiers with occult traumatic brain injury. Am J Phys Med Rehabil. 2005;84:393-398.
117. Hoge CW, McGurk D, Thomas JL, et al. Mild traumatic brain injury in US soldiers returning from Iraq. N Engl J Med. 2008;358:453-463.
118. King NS. PTSD and traumatic brain injury: folklore and fact? Brain Inj. 2008;22:1-5.
119. Stein MB, McAllister TW. Exploring the convergence of posttraumatic stress disorder and mild traumatic brain injury. Am J Psychiatry. 2009;166:768-776.
120. Brenner LA, Ivins BJ, Schwab K, et al. Traumatic brain injury, posttraumatic stress disorder, and postconcussive symptoms reporting among troops returning from Iraq. J Head Trauma Rehabil. 2010;25:307-312.
121. Sayeed I, Stein DG. Progesterone as a neuroprotective factor in traumatic and ischemic brain injury. Prog Brain Res. 2009;175:219-237.
122. Stein DG. Progesterone in the treatment of acute traumatic brain injury: a clinical perspective and update. Neuroscience. 2011;191:101-106.
123. Griesbach GS, Hovda DA, Tio DL, et al. Heightening of the stress response during the first weeks after a mild traumatic brain injury. Neuroscience. 2004;178:147-158.
124. Asiedu MN, Mejia G, Ossipov MK, et al. Modulation of spinal GABAergic analgesia by inhibition of chloride extrusion capacity in mice. J Pain. 2012;13:546-554.
125. Gomez-Piniella F, Zhuang Y, Feng J, et al. Exercise impacts brain-derived neurotorphic factor plasticity by engaging mechanisms of epigenetic regulation. Eur J Neurosci. 2011;33:383-390.
126. Elsner VR, Lovatel GA, Bertoldi K, et al. Effect of different exercise protocols on histone acetyltransferases and histone deacetylases activities in rat hippocampus. Neuroscience. 2011;192:580-587.
127. Elsner VR, Lovatel GA, Moyses F, et al. Exercise induces age-dependent changes on epigenetic parameters in rat hippocampus: a preliminary study. Exp Gerontol. 2013;48:136-139.
128. Manger TA, Motta RW. The impact of an exercise program on posttraumatic stress disorder, anxiety and depression. Int J Emerg Ment Health. 2005;7:49-57.
129. Landers DM, Arent SM. Physical activity and mental health. In: Tenenbaum G, Eklund RC, eds. Handbook of Sport Psychology. Hoboken, NJ: Wiley & Sons; 2007:469-491.
130. McBeth J, Prescott G, Scotland G, et al. Cognitive behavior therapy, exercise, or both for treating chronic widespread pain. Arch Intern Med. 2012;172:48-57.
131. Chatzitheodorou D, Kabitsis C, Malliou P, et al. A pilot study of the effects of high-intensity aerobic exercise versus passive interventions on pain, disability, psychological strain and serum cortisol concentrations in people with chronic low back pain. Phys Ther. 2007;87:304-312.
132. Koltyn KF. Exercise-induced hypoalgesia and intensity of exercise. Sports Med. 2002;32:477-487.
133. NaugleKM, Fillingim RB, Riley JL III. A meta-analytic review of the hypoalgesic effects of exercise. J Pain. 2012;13:1139-1150.
134. Pernow J, Lundberg JM, Kaliser L, et al. Plasma neuropeptide Y-like immunoreactivity and catecholamines during various degrees of sympathetic activation in man. Clin Physiol. 1986;6:561-578.
135. Lewandowski J, Pruszczyk ME, Chodakowska J, et al. Blood pressure, plasma NPY and catecholamines during physical exercise in relation to menstrual cycle, ovariectomy and estrogen replacement. Regul Pept. 1998;75-76:239-245.
136. Genazzani AR, Salvestroni C, Guo AL, et al. Neurosteroids and regulation of neuroendocrine function. In: Genazzani AR, Petaglia F, Purdy R II, eds. The Brain: Source and Target for Sex Steroid Hormones. New York: The Parthenon; 1996:83-91.